Skip to main content

Table 1 Baseline characteristics

From: Predictors for pulmonary artery involvement in Takayasu arteritis and its cluster analysis

 

TAK with PAI (n=65)

TAK without PAI (n=76)

P value

Clinical characteristics

 Disease duration (months)

96 (24,174)

42 (6,120)

0.012

 Female sex, n (%)

62 (95.4)

70 (92.1)

0.654

 Age (years)

39 ± 12

38 ± 12

0.447

 Age of onset (years)

29 ± 11

31 ± 12

0.662

 BMI

22.90 ± 3.78

21.81 ± 2.84

0.116

Numano subtype

 Type I, n (%)

5 (7.69)

11 (14.5)

0.206

 Type IIa, n (%)

5 (7.69)

2 (2.63)

0.322

 Type IIb, n (%)

13 (20.0)

12 (15.8)

0.514

 Type III, n (%)

1 (1.54)

5 (6.58)

0.289

 Type IV, n (%)

0 (0)

5 (6.58)

0.099

 Type V, n (%)

41 (63.1)

41 (53.9)

0.273

Symptoms

 Hemoptysis, n (%)

7 (10.8)

1 (1.32)

0.040

 Oppression in the chest, n (%)

26 (40.0)

16 (21.1)

0.014

 Fever, n (%)

15 (23.1)

7 (9.21)

0.024

 Dizziness, n (%)

30 (46.2)

38 (50.0)

0.649

 Palpitations, n (%)

10 (15.4)

10 (13.1)

0.706

 Chest pain, n (%)

15 (23.1)

16 (21.1)

0.772

Comorbidities and personal history

 Mycobacterium tuberculosis infection, n (%)

14 (21.5)

5 (6.57)

0.010

 PAH, n (%)

14 (21.5)

2 (2.6)

<0.001

 Pulmonary infarction, n (%)

27 (41.5)

0 (0)

<0.001

 Hypoxemia, n (%)

12 (18.5)

1 (1.3)

<0.001

 Hypertension, n (%)

19 (29.2)

26 (34.2)

0.527

 Diabetes mellitus, n (%)

3 (4.62)

6 (7.89)

0.654

 Hyperlipidemia, n (%)

6 (9.23)

13 (17.1)

0.172

 Coronary heart disease, n (%)

9 (13.8)

5 (6.58)

0.150

 Cerebrovascular disease, n (%)

2 (3.08)

6 (7.89)

0.386

 History of smoking, n (%)

3 (4.62)

7 (9.21)

0.465

 History of alcohol, n (%)

1 (1.54)

5 (6.58)

0.289

Blood biochemistry, inflammatory markers, and disease activity

 WBC (109/L)

7.4 ± 2.5

7.1 ± 2.6

0.484

 HGB (109/L)

120 ± 20

120 ± 17

0.957

 PLT (109/L)

283 ± 96

269 ± 86

0.795

 ESR (mm/1h)

17 (7, 36)

17 (10, 30)

0.826

 CRP (mg/l)

5.96 (1.14, 19.86)

3.03(0.59, 8.29)

0.056

 NIH score

2 (2, 3)

2 (2, 3)

0.330

The artery involvement

 Common carotid artery, n (%)

55 (84.6)

55 (72.4)

0.080

 Vertebral artery, n (%)

23 (35.4)

23 (30.3)

0.518

 Arteria subclavia, n (%)

58 (89.2)

60 (78.9)

0.099

 Superior mesenteric artery, n (%)

18 (27.7)

20 (26.3)

0.854

 Renal artery, n (%)

18 (27.7)

31 (40.8)

0.104

 Common iliac artery, n (%)

9( 13.8)

13 (17.1)

0.595

 Thoracic aorta, n (%)

56 (86.2)

45 (59.2)

<0.001

 Aorta abdominalis, n (%)

34 (52.3)

41 (53.9)

0.846

  1. TAK Takayasu’s arteritis, PAI pulmonary artery involvement, PAH pulmonary arterial hypertension, WBC white blood cell, HGB hemoglobin, PLT platelet count, ESR erythrocyte sedimentation rate, CRP C-reactive protein, NIH National Institutes of Health